Eastman Kodak Co plan sell 2.3 pct hold ICN Pharmaceuticals ICN> nine pct holding Viratek VIRA>. It purpose investment lay groundwork creation Nucleic Acid Research Institute. Since achieve longer reason maintain equity position Kodak said. Kodak hold 470000 sahres ICN currently trading 18-3/4 700000 Viratek trading 44. Reuter 